Alan J. Tuchman - Nov 15, 2022 Form 4/A - Amendment Insider Report for Synaptogenix, Inc. (SNPX)

Role
Chief Executive Officer, Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Stock symbol
SNPX
Transactions as of
Nov 15, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/1/2022, 06:46 PM
Date Of Original Report
Nov 17, 2022
Previous filing
Feb 22, 2022
Next filing
Dec 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPX Stock Option (Right to Buy) Award $0 +68.9K $0.00 68.9K Nov 15, 2022 Common Stock, par value $0.0001 per share 68.9K $6.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing amends the Form 4, filed on November 17, 2022 by Mr. Tuchman to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended.
F2 These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer.